Biohaven adds John Yetimoglu to board of directors

Biohaven Ltd. disclosed in an 8-K filed with the SEC that on August 3, 2026, the Board of Directors of Biohaven Ltd. appointed John Yetimoglu as a director, effective August 6, 2026.¹

Yetimoglu will serve in the class of directors whose term expires at the Company's 2027 Annual Meeting of Shareholders.¹ He has also been appointed as a member of the Nominating and Governance Committee of the Board.¹

The filing states there is no arrangement or understanding between Yetimoglu and any other person pursuant to which he was selected as a director of the Company, and there is no family relationship between Yetimoglu and any of the Company's other directors or executive officers.¹ It also notes since the beginning of the Company's last fiscal year, there are no transactions in which the Company was or is to be a participant and in which Yetimoglu or any member of his immediate family had or will have any interest that are required to be reported under Item 404(a) of Regulation S-K.¹

On compensation, the filing states in accordance with the Company's compensation policy for non-employee directors, Yetimoglu is entitled to options to purchase the Company's common shares with an aggregate grant date fair value of $713,875.¹ The shares underlying these options will vest 25% on grant and 25% on each of the following three anniversaries of grant, subject to Yetimoglu's continuous service through each vesting date.¹ Additionally, Yetimoglu will be entitled to receive a $57,000 annual retainer for his service as a director and committee member.¹

The report was signed by Chief Financial Officer Matthew Buten and dated August 7, 2026.